Mutations of peroxisome proliferator-activated receptor gamma (PPARγ): Clinical implications

COMMENTARY ON THE LAW

Mutations of peroxisome proliferator-activated receptor gamma (PPARγ): Clinical implications

Małgorzata Gacka 1 , Rajmund Adamiec 2

1. Katedra i Klinika Angiologii, Nadciśnienia Tętniczego i Diabetologii AM we Wrocławiu
2. Katedra i Klinika Angiologii, Nadciśnienia Tętniczego i Diabetologii Akademii Medycznej we Wrocławiu

Published: 2004-12-14
GICID: 01.3001.0000.3623
Available language versions: en pl
Issue: Postepy Hig Med Dosw 2004; 58 (0)

 

Abstract

The cardiovascular complications of metabolic syndrome are induced by unfavorable environmental and genetic factors. One of the most important genes under consideration codes peroxisome proliferator-activated receptor γ (PPAR γ), a nuclear transcription factor which has wide influence on metabolism. The activation of PPARg controls glycemia, lipidemia, adipogenesis, and endothelium function and diminishes insulin resistance. This review discusses the role of the most frequent mutations of the pparγ gene in metabolic syndrome: Pro467Leu and Val290Met, which are connected with severe insulin resistance, Pro115Gln, which is connected with obesity, and Pro12Ala, which can influence the development of diabetes or hypertension.

Full text

Skip to content